Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 Biomarker disease BEFREE Both GR and MR are deeply involved in adipogenesis and adipose expansion; hence pharmacological blockade of these two receptors has proven effective against adipose tissue dysfunction in experimental models of obesity and metabolic syndrome (MetS), suggesting a potential use for MR and GR antagonists in these clinical settings. 28915330 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 AlteredExpression disease BEFREE To evaluate hypothalamic-pituitary-adrenal (HPA) axis sensitivity to dexamethasone (DEX), NR3C1 single nucleotide polymorphisms (SNPs), and expression of glucocorticoid receptor (GR) isoforms and cytokines in peripheral immune cells of MetS patients and controls. 27507764 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation disease BEFREE The glucocorticoid receptor single-nucleotide polymorphism (SNP) N363S has been reported to be associated with metabolic syndrome, type 2 diabetes, and cardiovascular disease. 27600822 2016
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation disease BEFREE The objective of our study is to evaluate the effects of GR gene polymorphisms (BclI, N363S, TthIII1 and ER22/23EK) in Turkish patients with MetS. 26596278 2016
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation disease BEFREE No main effects of functional GR haplotypes on MetS were found, but the association of GR haplotype 4 (containing N363S) with MetS was influenced by interaction with age, sex and education status (P < 0.05). 27634941 2016
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation disease BEFREE Fourteen tag-SNPs and five functionally important SNPs in the NR3C1 gene were genotyped in MetS patients (n = 431) and normal controls (n = 461) using the high-throughput Sequenom genotyping platform. 25104270 2014
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 Biomarker disease BEFREE Three genes in EDdb (ADIPO (adiponectin), TNF (tumor necrosis factor) and NR3C1 (nuclear receptor subfamily 3, group C, member 1)) link the KEGG (Kyoto Encyclopedia of Genes and Genomes) "adipocytokine signaling pathway" with the BioCarta "visceral fat deposits and the metabolic syndrome" pathway to form a joint pathway. 24302289 2013
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation disease BEFREE Previous studies of the N363S and BclI SNP in the GR gene have shown a metabolic syndrome phenotype in mostly non-African populations. 22801563 2013
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation disease BEFREE As the effects of glucocorticoids are mediated by the glucocorticoid receptor, encoded by NR3C1 gene, different polymorphisms in the NR3C1 gene have been linked to altered glucocorticoid sensitivity in general population as well as in patients with obesity or metabolic syndrome. 22587831 2012
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 Biomarker disease BEFREE Hepatic mRNA levels of these genes were higher in obese patients with MS (11β-HSD1, P = 0.002; H6PDH, P = 0.043; GR, P = 0.033; PEPCK, P = 0.032) and positively correlated with the number of clinical characteristics that define the MS. 21964795 2012
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 Biomarker disease BEFREE The glucocorticoid receptor (GR) may be a common link between human obesity/metabolic syndrome and Cushing's syndrome. 16855182 2006
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation disease BEFREE The N363S polymorphism of the glucocorticoid receptor and metabolic syndrome factors in men. 15919839 2005
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation disease BEFREE Although several other mutations in the GR gene have been postulated as being relevant to the progression to type 2 diabetes and cardiovascular diseases, conflicting results makes it difficult to determine exactly what effect these GR variations have on metabolic syndrome incidence and progression. 12376590 2002
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 AlteredExpression disease BEFREE Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. 11916927 2002